However, serum LDHB-positive NSCLC patients presented higher recurrence-free survival rates than did LDHB-negative cases, particularly those of the squamous cell carcinoma subtype (Koh et al., 2017b). This evidence concerns the gene LDHB and squamous cell carcinoma.